135 related articles for article (PubMed ID: 15257315)
1. Mantle cell lymphomas with clonal immunoglobulin V(H)3-21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin V(H) genes.
Thelander EF; Walsh SH; Thorsélius M; Laurell A; Landgren O; Larsson C; Rosenquist R; Lagercrantz S
Mod Pathol; 2005 Mar; 18(3):331-9. PubMed ID: 15257315
[TBL] [Abstract][Full Text] [Related]
2. Clonal development of a blastoid mantle cell lymphoma studied with comparative genomic hybridization.
Flordal E; Berglund M; Rosenquist R; Erlanson M; Enblad G; Roos G; Larsson C; Lagercrantz S
Cancer Genet Cytogenet; 2002 Nov; 139(1):38-43. PubMed ID: 12547156
[TBL] [Abstract][Full Text] [Related]
3. Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature.
Salaverria I; Zettl A; Beà S; Moreno V; Valls J; Hartmann E; Ott G; Wright G; Lopez-Guillermo A; Chan WC; Weisenburger DD; Gascoyne RD; Grogan TM; Delabie J; Jaffe ES; Montserrat E; Muller-Hermelink HK; Staudt LM; Rosenwald A; Campo E
J Clin Oncol; 2007 Apr; 25(10):1216-22. PubMed ID: 17296973
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin VH somatic hypermutation in mantle cell lymphoma: mutated genotype correlates with better clinical outcome.
Lai R; Lefresne SV; Franko B; Hui D; Mirza I; Mansoor A; Amin HM; Ma Y
Mod Pathol; 2006 Nov; 19(11):1498-505. PubMed ID: 16980950
[TBL] [Abstract][Full Text] [Related]
5. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants.
Beà S; Ribas M; Hernández JM; Bosch F; Pinyol M; Hernández L; García JL; Flores T; González M; López-Guillermo A; Piris MA; Cardesa A; Montserrat E; Miró R; Campo E
Blood; 1999 Jun; 93(12):4365-74. PubMed ID: 10361135
[TBL] [Abstract][Full Text] [Related]
6. High-resolution genomic screening in mantle cell lymphoma--specific changes correlate with genomic complexity, the proliferation signature and survival.
Halldórsdóttir AM; Sander B; Göransson H; Isaksson A; Kimby E; Mansouri M; Rosenquist R; Ehrencrona H
Genes Chromosomes Cancer; 2011 Feb; 50(2):113-21. PubMed ID: 21117067
[TBL] [Abstract][Full Text] [Related]
7. Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma.
Walsh SH; Thorsélius M; Johnson A; Söderberg O; Jerkeman M; Björck E; Eriksson I; Thunberg U; Landgren O; Ehinger M; Löfvenberg E; Wallman K; Enblad G; Sander B; Porwit-MacDonald A; Dictor M; Olofsson T; Sundström C; Roos G; Rosenquist R
Blood; 2003 May; 101(10):4047-54. PubMed ID: 12637326
[TBL] [Abstract][Full Text] [Related]
8. t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia.
Bentz M; Plesch A; Bullinger L; Stilgenbauer S; Ott G; Müller-Hermelink HK; Baudis M; Barth TF; Möller P; Lichter P; Döhner H
Genes Chromosomes Cancer; 2000 Mar; 27(3):285-94. PubMed ID: 10679918
[TBL] [Abstract][Full Text] [Related]
9. Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions.
Kohlhammer H; Schwaenen C; Wessendorf S; Holzmann K; Kestler HA; Kienle D; Barth TF; Möller P; Ott G; Kalla J; Radlwimmer B; Pscherer A; Stilgenbauer S; Döhner H; Lichter P; Bentz M
Blood; 2004 Aug; 104(3):795-801. PubMed ID: 15090459
[TBL] [Abstract][Full Text] [Related]
10. Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma.
Monni O; Oinonen R; Elonen E; Franssila K; Teerenhovi L; Joensuu H; Knuutila S
Genes Chromosomes Cancer; 1998 Apr; 21(4):298-307. PubMed ID: 9559341
[TBL] [Abstract][Full Text] [Related]
11. VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome.
Kienle D; Kröber A; Katzenberger T; Ott G; Leupolt E; Barth TF; Möller P; Benner A; Habermann A; Müller-Hermelink HK; Bentz M; Lichter P; Dōhner H; Stilgenbauer S
Blood; 2003 Oct; 102(8):3003-9. PubMed ID: 12842981
[TBL] [Abstract][Full Text] [Related]
12. Leukemic involvement is a common feature in mantle cell lymphoma.
Ferrer A; Salaverria I; Bosch F; Villamor N; Rozman M; Beà S; Giné E; López-Guillermo A; Campo E; Montserrat E
Cancer; 2007 Jun; 109(12):2473-80. PubMed ID: 17477385
[TBL] [Abstract][Full Text] [Related]
13. High incidence of unbalanced chromosomal changes in mantle cell lymphoma detected by comparative genomic hybridization.
Jarosová M; Papajík T; Holzerová M; Dusek L; Pikalová Z; Lakomá I; Raida L; Faber E; Divoká M; Vlachová S; Prekopová I; Novosadová A; Pospísilová H; Indrák K
Leuk Lymphoma; 2004 Sep; 45(9):1835-46. PubMed ID: 15223644
[TBL] [Abstract][Full Text] [Related]
14. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
Kröber A; Seiler T; Benner A; Bullinger L; Brückle E; Lichter P; Döhner H; Stilgenbauer S
Blood; 2002 Aug; 100(4):1410-6. PubMed ID: 12149225
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas.
Navarro A; Beà S; Fernández V; Prieto M; Salaverria I; Jares P; Hartmann E; Mozos A; López-Guillermo A; Villamor N; Colomer D; Puig X; Ott G; Solé F; Serrano S; Rosenwald A; Campo E; Hernández L
Cancer Res; 2009 Sep; 69(17):7071-8. PubMed ID: 19690137
[TBL] [Abstract][Full Text] [Related]
16. Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer.
Mahlamäki EH; Höglund M; Gorunova L; Karhu R; Dawiskiba S; Andrén-Sandberg A; Kallioniemi OP; Johansson B
Genes Chromosomes Cancer; 1997 Dec; 20(4):383-91. PubMed ID: 9408755
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization.
Allen JE; Hough RE; Goepel JR; Bottomley S; Wilson GA; Alcock HE; Baird M; Lorigan PC; Vandenberghe EA; Hancock BW; Hammond DW
Br J Haematol; 2002 Feb; 116(2):291-8. PubMed ID: 11841429
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma.
Gutiérrez NC; García JL; Hernández JM; Lumbreras E; Castellanos M; Rasillo A; Mateo G; Hernández JM; Pérez S; Orfao A; San Miguel JF
Blood; 2004 Nov; 104(9):2661-6. PubMed ID: 15238415
[TBL] [Abstract][Full Text] [Related]
19. Genomic aberrations in carcinomas of the uterine corpus.
Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
[TBL] [Abstract][Full Text] [Related]
20. Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations.
Camacho FI; Algara P; Rodríguez A; Ruíz-Ballesteros E; Mollejo M; Martínez N; Martínez-Climent JA; González M; Mateo M; Caleo A; Sánchez-Beato M; Menárguez J; García-Conde J; Solé F; Campo E; Piris MA
Blood; 2003 May; 101(10):4042-6. PubMed ID: 12511405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
